glp 1 agonist drugs side effects Managing of GLP-1 Receptor Agonists – Transformation Weight Control Benefits and Risks of GLP-1

Leon N, LaCoursiere R, Yarosh D, Patel RS

These lipid modifications, combined with weight loss and improved glycemic control, contribute to a more favorable cardiovascular profile

However, concerns have recently emerged about the long-term cardiovascular safety of antidiabetic medications, and U.S

By analyzing the reported adverse events in the US Food and Drug Administrations database, Elashoff reported that treatment with DPP4 inhibitor sitagliptin or GLP-1R agonist exenatide increased the risk of pancreatitis and pancreatic cancer as compared with other therapies

Available from: [Google Scholar] 50.Finan B, Ma T, Ottaway N, Muller TD, Habegger KM, Heppner KM, et al